Girishanthy Krishnarajah

2.1k total citations
63 papers, 1.7k citations indexed

About

Girishanthy Krishnarajah is a scholar working on Epidemiology, Health and Infectious Diseases. According to data from OpenAlex, Girishanthy Krishnarajah has authored 63 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Epidemiology, 22 papers in Health and 16 papers in Infectious Diseases. Recurrent topics in Girishanthy Krishnarajah's work include Vaccine Coverage and Hesitancy (22 papers), Influenza Virus Research Studies (16 papers) and Bacterial Infections and Vaccines (13 papers). Girishanthy Krishnarajah is often cited by papers focused on Vaccine Coverage and Hesitancy (22 papers), Influenza Virus Research Studies (16 papers) and Bacterial Infections and Vaccines (13 papers). Girishanthy Krishnarajah collaborates with scholars based in United States, Netherlands and United Kingdom. Girishanthy Krishnarajah's co-authors include Luba Nalysnyk, D. Yin, Panagiotis Mavros, R. Lyu, Cristina Masseria, Keith L. Davis, Samantha K. Kurosky, Santiago Tofé, Fernando Álvarez Guisasola and John Graham and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Allergy and Clinical Immunology.

In The Last Decade

Girishanthy Krishnarajah

62 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Girishanthy Krishnarajah United States 21 654 593 267 262 215 63 1.7k
Alison D. Lydecker United States 14 348 0.5× 1.3k 2.1× 33 0.1× 277 1.1× 43 0.2× 30 1.7k
Carlo Lucioni Italy 16 229 0.4× 361 0.6× 55 0.2× 68 0.3× 39 0.2× 76 1.1k
M. Valle Finland 21 220 0.3× 404 0.7× 150 0.6× 168 0.6× 13 0.1× 72 1.5k
F. Raffi France 21 85 0.1× 734 1.2× 51 0.2× 721 2.8× 36 0.2× 71 1.5k
Eva Wolf Germany 24 165 0.3× 803 1.4× 29 0.1× 867 3.3× 23 0.1× 108 2.3k
Elias David‐Neto Brazil 25 654 1.0× 460 0.8× 33 0.1× 300 1.1× 9 0.0× 151 2.6k
Ana Correa United Kingdom 13 161 0.2× 354 0.6× 69 0.3× 54 0.2× 17 0.1× 27 862
Marcela Guevara Spain 27 28 0.0× 789 1.3× 258 1.0× 370 1.4× 72 0.3× 102 1.7k
E. Riva Italy 23 88 0.1× 410 0.7× 22 0.1× 379 1.4× 21 0.1× 123 1.7k
Srinivas Rao Valluri United States 15 166 0.3× 137 0.2× 454 1.7× 1.0k 3.8× 13 0.1× 44 1.6k

Countries citing papers authored by Girishanthy Krishnarajah

Since Specialization
Citations

This map shows the geographic impact of Girishanthy Krishnarajah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Girishanthy Krishnarajah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Girishanthy Krishnarajah more than expected).

Fields of papers citing papers by Girishanthy Krishnarajah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Girishanthy Krishnarajah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Girishanthy Krishnarajah. The network helps show where Girishanthy Krishnarajah may publish in the future.

Co-authorship network of co-authors of Girishanthy Krishnarajah

This figure shows the co-authorship network connecting the top 25 collaborators of Girishanthy Krishnarajah. A scholar is included among the top collaborators of Girishanthy Krishnarajah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Girishanthy Krishnarajah. Girishanthy Krishnarajah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
DeMartino, Jessica K., Marie‐Hélène Lafeuille, Bruno Émond, et al.. (2023). Respiratory Syncytial Virus–Related Complications and Healthcare Costs Among a Medicare-Insured Population in the United States. Open Forum Infectious Diseases. 10(5). ofad203–ofad203. 7 indexed citations
2.
3.
Pelton, Stephen I., Maarten J. Postma, Victoria Divino, et al.. (2020). PIN3 RELATIVE VACCINE EFFECTIVENESS OF QUADRIVALENT CELL-BASED VERSUS EGG-BASED INFLUENZA VACCINES AMONG ADULTS 50-64 YEARS OLD: A U.S. OBSERVATIONAL COHORT STUDY. Value in Health. 23. S168–S168. 2 indexed citations
4.
5.
Bernstein, Jonathan A., Timothy Craig, Michael Manning, et al.. (2019). Indirect comparison of intravenous vs. subcutaneous C1-inhibitor placebo-controlled trials for routine prevention of hereditary angioedema attacks. Allergy Asthma and Clinical Immunology. 15(1). 13–13. 13 indexed citations
6.
Hechter, Rulin C., Lei Qian, Yi Luo, et al.. (2018). Impact of an electronic medical record reminder on hepatitis B vaccine initiation and completion rates among insured adults with diabetes mellitus. Vaccine. 37(1). 195–201. 20 indexed citations
7.
Hechter, Rulin C., Lei Qian, Songkai Yan, et al.. (2017). Impact of the change of copay policy in Medicare Part D on zoster vaccine uptake among Medicare beneficiaries in a managed care organization. BMC Health Services Research. 17(1). 503–503. 6 indexed citations
8.
Levin, Myron J., Juliana Meyers, Sean D. Candrilli, et al.. (2017). COST OF DIAGNOSED HERPES ZOSTER COMPLICATIONS IN PATIENTS AGE ≥50 YEARS: A U.S. CLAIMS DATA ANALYSIS. Innovation in Aging. 1(suppl_1). 902–902. 2 indexed citations
9.
Chen, Chi‐Chang, Catherine B. McGuiness, Girishanthy Krishnarajah, et al.. (2016). Estimated incidence of pertussis in people aged <50 years in the United States. Human Vaccines & Immunotherapeutics. 12(10). 2536–2545. 14 indexed citations
10.
Krishnarajah, Girishanthy, et al.. (2016). Rotavirus vaccination in a Medicaid infant population from four US states: compliance, vaccination completion rate, and predictors of compliance. Human Vaccines & Immunotherapeutics. 12(5). 1235–1243. 9 indexed citations
11.
Curran, Desmond, et al.. (2016). Vaccine Timeliness. The Pediatric Infectious Disease Journal. 35(5). 542–547. 19 indexed citations
12.
Masseria, Cristina, Ami Buikema, Fang Liu, & Girishanthy Krishnarajah. (2015). Mixing of diphtheria, tetanus and acellular pertussis (DTaP) vaccines in a population of children in managed care. Human Vaccines & Immunotherapeutics. 11(5). 0–0. 2 indexed citations
13.
Varghese, Lijoy, et al.. (2015). Estimating the Potential Public Health Impact of Introducing the HZ/su Vaccine in the US Population Aged ≥50 Years. Open Forum Infectious Diseases. 2(suppl_1). 4 indexed citations
14.
Naleway, Allison L., Sheila Weinmann, Girishanthy Krishnarajah, et al.. (2015). Pregnancy after Treatment for Cervical Cancer Precursor Lesions in a Retrospective Matched Cohort. PLoS ONE. 10(2). e0117525–e0117525. 10 indexed citations
15.
Krishnarajah, Girishanthy, Charlotte Carroll, Julie Priest, et al.. (2014). Burden of vaccine-preventable disease in adult Medicaid and commercially insured populations. Human Vaccines & Immunotherapeutics. 10(8). 2460–2467. 14 indexed citations
16.
Curran, Desmond, et al.. (2013). Vaccine Timeliness: A Cost Analysis of the Implications of Delayed Vaccination. Value in Health. 16(7). A346–A346. 3 indexed citations
17.
McGarry, Lisa J., Girishanthy Krishnarajah, Cristina Masseria, et al.. (2012). Cost-effectiveness analysis of BOOSTRIX® (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) among Individuals≥ 65 years of age in prevention of Pertussis. 201201. 2 indexed citations
18.
Annunziata, K., et al.. (2012). Vaccination Rates among the General Adult Population and High-Risk Groups in the United States. PLoS ONE. 7(11). e50553–e50553. 46 indexed citations
19.
Nalysnyk, Luba, et al.. (2009). Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Diabetes Obesity and Metabolism. 12(4). 288–298. 272 indexed citations
20.
Maclean, J. Ross, et al.. (2009). Drug titration patterns and HbA1clevels in type 2 diabetes. International Journal of Clinical Practice. 63(7). 1008–1016. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alison D. Lydecker Breakdown of academic impact, for papers by Carlo Lucioni Breakdown of academic impact, for papers by M. Valle Breakdown of academic impact, for papers by F. Raffi Breakdown of academic impact, for papers by Eva Wolf Breakdown of academic impact, for papers by Elias David‐Neto Breakdown of academic impact, for papers by Ana Correa Breakdown of academic impact, for papers by Marcela Guevara Breakdown of academic impact, for papers by E. Riva Breakdown of academic impact, for papers by Srinivas Rao Valluri
Rankless by CCL
2026